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Oropharyngeal squamous cell carcinoma (OSCC) may 
originate in the soft palate, tongue base, pharyngeal 
walls or tonsils. The association of high-risk human 
papillomavirus (hrHPV) types with increased risk 
for a subset of OSCC has been established by many 
studies.[1-5] It has been shown that oral human papillomavirus (HPV) 
infection, and specifically HPV type 16 infection, causes an up to 
50-fold increase in HPV-positive OSCC.[6] The pathogenic association 
of OSCC with HPV was therefore recently accepted by the International 
Agency for Research on Cancer.[7] Head and neck cancer (HNC), of 
which OSCC is a subset, is the sixth most common cancer in the world. 
In South Africa (SA) there has been a proven increase in OSCC since 
1995, and 90% of these cancers were associated with HPV 16.[8] Males 
were affected more frequently than females.[8] Gillison et al.[9] recently 
published the first population-based study that concurrently examined 
the epidemiology of oral HPV infection among males and females 
and showed an almost three-fold higher HPV prevalence in males; 
the HPV 16 prevalence was five-fold higher in males than in females.
The aims of this pilot study were to determine the oral and 
oropharyngeal HPV strain prevalence in a selected male population 
in Pretoria, SA, as well as the association of HPV with sexual 
practices and substance use.
Methods
Participant selection
Male participants were voluntarily recruited from an industrial factory 
in Pretoria in 2012. Written informed consent was obtained from 
each participant for HPV testing and answering the questionnaire. 
Separate consent was obtained for voluntary HIV testing. Refusal of 
HIV testing did not serve as a criterion for exclusion from the study, 
but refusal of HPV testing did. Approval for the study was obtained 
from the Ethics Committee of the Faculty of Health Sciences, 
University of Pretoria (no. 101/2012).
Clinical examination and saliva sample  
collection
Participants underwent a thorough oral and oropharyngeal clinical 
examination by a senior dentist/oral pathologist. All dental and other 
soft-tissue abnormalities were noted and photographed.
Oral rinse samples were collected by means of a 20-second oral 
rinse and gargle with 5 ml phosphate-buffered saline (PBS) (Sigma 
Life Sciences, USA) given to the patient in a 40 ml sterile collection 
cup (Lasec, SA). Participants alternately swished and gargled and 
then expectorated the saliva into the cup. All samples were numbered 
consecutively and stored on ice until sample preparation.
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Background. Human papillomavirus (HPV) infection is well known to be associated with head and neck cancers (HNCs). HPV-associated 
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Objectives. To determine the oral and oropharyngeal HPV strain prevalence and associated factors in a selected male population in 
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Methods. Male factory workers were recruited. Oral rinse and gargle samples were tested for 37 HPV types using the Linear Array HPV 
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and alcohol use and sexual behaviour. HIV testing was optional.
Results. The HPV prevalence was 5.6% among men (N=125) aged 17 - 64 years. High-risk HPV (hrHPV) types 16 and 68 were found in 
two men. Oral sex seemed to be an uncommon practice in the majority of respondents, but the two respondents with hrHPV did practise 
oral sex. There was a statistically significant association between HPV infection and an increased number of sexual partners (p=0.027), but 
not between HPV and substance use, HIV status or clinical mucosal pathology.
Conclusion. The prevalence of oral and oropharyngeal HPV was lower than reported in other countries. An association between oral HPV 
and having multiple sexual partners was found. A larger nationwide study would give a more representative view of the burden of oral and 
oropharyngeal HPV infection in SA.
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Questionnaire
The questionnaire comprised specifically 
formulated questions pertaining to past 
and present sexual histories, substance and 
alcohol use and any medical conditions. The 
numbers of the questionnaires corresponded 
with the oral rinse samples, and their content 
was treated as confidential.
Voluntary HIV counselling and 
testing
Participants who opted for HIV testing received 
pre-test counselling from the occupational 
health practitioner (OHP) of the company. 
A rapid point-of-care HIV screening test (U 
test HIV/AIDS, Humor Diagnostica, SA) that 
detects HIV-1 and HIV-2 antibodies was then 
performed according to the manufacturer’s 
instructions. Confirmatory follow-up testing 




Saliva samples were prepared for HPV 
genotyping within 24 hours of collection. 
The samples were washed three times with 
sterile PBS and the cell pellets were stored 
at -70°C until subsequent DNA extraction.
DNA extraction
DNA extraction from the cell pellets was 
performed using the DNA Isolation Kit 
(Roche Molecular Systems, USA) on the 
MagNA Pure automated extraction system.
HPV DNA amplification and 
genotyping
HPV DNA amplification and genotyping was 
done using the Linear Array HPV Genotyping 
Test (Roche Molecular Systems). The pool of 
primers in the kit are designed to amplify 
HPV DNA from 15 high-risk genotypes (16, 
18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68, 73 
and 82), 3 probable high-risk genotypes (26, 
53 and 66) and 19 low/undetermined risk 
types (6, 11, 40, 42, 54, 55, 61, 62, 64, 67, 69, 
70, 71, 72, 81, 83, 84, IS39 and CP6108).[10] 
The β-globin gene was amplified concurrently 
for each sample and served as internal control 
for cellular adequacy, extraction efficiency 
and amplification.
Statistical analysis
The relationship between the prevalence 
of HPV and the prevalence of the variables 
substance use, alcohol use, sexual history, 
HIV and oral lesions was investigated 
using the chi-square test for independence 
or, where appropriate, Fisher’s exact test. 
The Kruskal-Wallis test was used to 
analyse whether or not any of the variables 
investigated had any significant influence on 
the HPV status of the participants.
Results
Oral rinse specimens were collected from 128 
males between the ages of 17 and 64 years 
(median 50). The participants originated from 
all over SA. Three participants who did not 
complete questionnaires were excluded from 
the study. Only 7/125 participants (5.6%) 
tested positive for HPV. One participant was 
co-infected with HPV types 71 and 72. Two 
Table 1. Summary of human papillomavirus status and results for the variables 








≤40 2 (28.6) 36 (30.5) 38 (30.4)
>40 5 (71.4) 82 (69.5) 87 (69.6)
Smoking 0.703
Yes 4 (57.1) 54 (45.8) 58 (46.4)
No 3 (42.9) 64 (54.2) 67 (53.6)
Alcohol 0.343
Yes 7 (100.0) 93 (78.8) 100 (80.0)
No 0 25 (21.2) 25 (20.0)
Lifetime sexual partners 0.027
0 - 5 1 (14.3) 19/117* (16.2) 20/124 (16.1)
5 - 20 2 (28.6) 79/117* (67.5) 81/124 (65.3)
>20 4 (57.1) 19/117* (16.2) 23/124 (18.5)
Sexual partners in the past 
6 months
1.000
None 0 (0) 3/117 (2.6) 3/124 (2.4)
1 - 3 7 (100) 104/117 (88.9) 111/124 (89.5)
>3 0 (0) 10/117 (8.5) 10/124 (8.1)
Practise oral sex 0.525
Yes 3 (42.9) 48 (40.7) 51 (40.8)
No 4 (57.1) 70 (59.3) 74 (59.2)
Lifetime oral sex partners 0.592
1 0 19/48 (39.6) 19/51 (37.3)
2 1/3 (33.3) 16/48 (33.3) 17/51 (33.3)
>2 2/3 (66.7) 17/48 (35.4) 19/51 (37.3)
Oral sex partners in the past 
6 months
0.518
None 4 (57.1) 83 (70.3) 87 (69.6)
1 2 (28.6) 26 (22.0) 28 (22.4)
>1 1 (14.3) 9 (7.6) 10 (8.0)
HIV 0.563
Positive 0 5 (4.2) 5 (4.0)
Negative 4 (57.1) 81 (68.6) 85 (68.0)
Declined testing 3 (42.9) 32 (27.1) 35 (28.0)
Clinical lesions 0.592
With 0 18 (15.3) 18 (14.4)
Without 7 (100.0) 100 (84.7) 107 (85.6)
HPV+ = HPV-positive; HPV- = HPV-negative.
*One questionnaire was not completed.
†Fisher’s exact test.
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participants tested positive for hrHPV types, namely HPV 16 and HPV 
68, respectively. Table 1 summarises the findings for all the variables 
investigated. The quantity and frequency of the different substances used 
were not investigated. An overall score was calculated, which only reflected 
whether a respondent used or did not use any of the substances listed in 
the questionnaire.
All participants were sexually active, 90/125 (72.0%) of them 
reporting having had their first sexual encounter between 15 and 20 
years of age. The association between HPV and the number of sexual 
partners was statistically significant (p=0.027).
In the subgroup of 90 men (72.0%) who volunteered for HIV 
testing, only five (5.5%) tested positive. Unfortunately only 4/7 HPV-
positive participants (57.1%) opted for HIV testing; one of these was 
found to have an hrHPV type. All the HPV-positive participants who 
tested for HIV were negative.
Only 18 of the 125 participants (14.4%) were found to have oral 
mucosal lesions on clinical examination. The lesions encountered 
included white lesions, red lesions, ulcerative lesions and Candida 
albicans infection. None of the HPV-positive participants had 
clinically visible mucosal pathology.
Table 2 summarises the findings for the variables investigated in 
the HPV-positive participants.
Discussion
The natural history of oral and oropharyngeal HPV infection in men 
is unknown. A recent study found the prevalence of oral HPV in men 
in the USA to be around 10%.[9] This pilot study among a group of 
SA men had an unexpectedly low HPV prevalence of only 5.6%. This 
could be attributed to the small sample size, or to the observation 
that oral sex did not seem to be a common practice among the group 
of men studied. A much larger nation-wide analysis with inter-
institutional collaboration will be necessary to confirm whether this 
figure is in fact truly representative of oral and oropharyngeal HPV 
in SA men. Known risk factors for oral and oropharyngeal HPV 
infection currently include lifetime number of sexual partners,[6,9,11] 
number of oral sex partners,[1,12] substance use[9,12-14] and infection 
with HIV.[15-18]
Sexual contact, either genital or oral, remains the primary mode 
of HPV transmission, and it is well documented that having multiple 
partners increases the prevalence of oral and genital HPV.[6,9,19,20] A 
study in KwaZulu-Natal, SA, reported male undergraduate students 
to have had a median of four sexual partners in the previous year.[11] 
In many African cultures it is acceptable for men to have multiple 
partners and engage in sex outside the primary relationship.[21,22] A 
statistically significant association between the number of sexual 
partners and the presence of oral HPV was seen in this study 
(p=0.027), with 4/7 HPV-positive participants having had >20 sexual 
partners and 2/7 having had between five and 20 partners. The 
numbers of sexual partners of the HPV-positive participants in the 
past 6 months ranged from one to three.
Tobacco use is an accepted cause of HNCs, but it is not considered 
a strong risk factor for HPV-associated oropharyngeal cancers.[1,6] We 
found no statistically significant association between smoking and the 
presence of HPV (p=0.703), although the only participant with HPV 
16 in our study was a current cigarette smoker. An increased oral HPV 
prevalence has been shown to be associated with current and previous 
smoking, but the exact pathogenic mechanisms are unknown.[12,13]
Alcohol has the ability to modify mucosal tissue, allowing easier 
entry of the virus, and is also known to modify the host immune 
response, thereby increasing susceptibility to HPV infection.[14,23] In 
our study we found no statistical association between alcohol use 
and HPV (p=0.343), although all the HPV-positive participants were 
current alcohol users.
The HIV pandemic and attempts to prevent spread of the 
virus have increasingly highlighted sexual practices other than 
penetrative sex. Oral sex has increased to a marked extent, 
especially among teenagers, as a result of the false perception 
that sexually transmitted diseases such as HIV infection cannot 
be passed on in this manner.[12,24] Studies on oral sex practices in 
the USA have shown that 19.6 - 78% of young adults had engaged 
in oral sex in their lifetime.[25] Gillison et al.,[9] in line with other 
studies, found oral sex performed on women to be one possible 
explanation for the increased prevalence of oropharyngeal HPV 
in males, who in their study on average had more partners than 
the females. Sexual behaviour studies in SA are few, and those that 
do exist are not specific in their data regarding genital versus oral 
sexual practices and the gender differences that exist. However, 
it was later discovered through the male fieldworker that most 
men in our study interpreted oral sex to mean contact of the 
female’s oral mucosa with the man’s genital mucosa rather than the 
other way around. This could explain the low prevalence of oral 
HPV. Only 51 of all participants (40.8%) and 3/7 HPV-positive 
participants (42.9%) answered ‘yes’ to the question whether they 
had practised oral sex. Considering the participants’ understanding 
of the definition of oral sex, one should be cautious in interpreting 
these figures. Of note was that both the individuals with hrHPV 
types said that they had had oral sex with more than one partner.
Oral HPV infection is considered to be bimodal in age distribution, 
with a high prevalence in younger men (30 - 34 years of age) and in 
later years (60 - 64).[9] The participants who were HPV-positive in this 
study were between 29 and 64 years of age, and those with hrHPV 
were between 50 and 60 years of age. It has been speculated that 
the higher HPV prevalence at older ages could be due to increased 
duration of infections at older ages, rather than an increased 
Table 2. Summary of human papillomavirus-positive results for all the variables investigated
HPV type/s Age (years) Smoking Alcohol Sex Oral sex HIV status Oral lesions
1 16 (hr) 51 Yes Yes Yes (m) Yes Declined testing No
2 55 59 Yes Yes Yes (m) No Declined testing No
3 62 46 No Yes Yes (m) No Negative No
4 68 (hr) 58 No Yes Yes Yes Negative No
5 70 29 Yes Yes Yes (m) No Declined testing No
6 71, 72 64 No Yes Yes (m) No Negative No
7 72 32 Yes Yes Yes (m) Yes Negative No
HPV = human papillomavirus; hr = high-risk HPV type; m = multiple sexual partners.
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acquisition of new HPV infections.[26] In our study, however, all the 
participants who were positive for HPV had had between one and 
three sexual partners in the past 6 months, suggesting that their HPV 
infections could have been newly acquired.
HIV-infected individuals have been reported to have an up to 
six-fold increased risk for HPV-related OSCC.[27] It is thought that 
HIV and HPV function as a combined risk factor, as HIV-positive 
individuals have more frequent HPV infections, but the natural 
history of these infections may be altered when they co-exist.[15] In 
SA, the total estimated number of adults aged 15 - 49 years living 
with HIV in 2013 was 5.26 million, giving an HIV prevalence of 
10%.[28] The HIV prevalence in this study was only 5.5%. Only four 
of the HPV-positive participants (n=7) volunteered to test for HIV, 
and all were negative. One of the participants who was found to have 
hrHPV 16, which is associated with OSCC, declined HIV testing. 
A much larger nationwide study with an HIV prevalence more 
representative of that for the country as a whole will be needed to 
determine the role of HIV infection in the natural history of oral and 
oropharyngeal HPV infection.
The 18 participants who presented with oral mucosal lesions were 
all negative for HPV. All patients with dental or mucosal pathology 
were referred to peripheral dental clinics or the Oral Medicine Clinic 
of the Oral and Dental Hospital, Pretoria, for surgical biopsies and 
clinical follow-up.
Study strength
Ours is the first study of this nature to investigate the oral and 
oropharyngeal HPV prevalence in SA men. Although the sample size 
was small, we did find a statistical association between HPV and the 
number of lifetime sexual partners.
Study limitations
The greatest limitation of this study is the small sample size, which 
was restricted owing to funding. Another limitation is the fact that 
not all the participants opted to test for HIV, which may also have 
an influence on the conclusions. Because this was a pilot study some 
of the conclusions made, including the role of HIV, will need to be 
verified by a larger, nationwide study.
Conclusion
In contrast to the prevalence of genital HPV in SA females and the 
role of the virus in the pathogenesis of cervical carcinoma, little is 
known about the prevalence of HPV in the oropharyngeal mucosa 
of SA men, who are known to acquire HPV-related OSCC more 
frequently than women. The prevalence of oral and oropharyngeal 
HPV in this study is lower than reported in other countries. Even 
though the number of participants was low, a statistically significant 
association was shown between oral and oropharyngeal HPV and 
having multiple sexual partners. Oral sex, although not practised by 
the majority of participants, was practised by those identified with 
hrHPV types. The high number of deaths from HPV-related cervical 
carcinoma and the increase in HPV-related OSCC, especially in 
males, makes it urgently necessary to investigate the prevalence of 
oral and oropharyngeal HPV in the larger SA population. Specific 
reference to the roles of sexual practices and HIV in the natural 
history of HPV is essential. Deeper investigations into the nature of 
sexual practices among South Africans are needed, and the diversity 
of the SA population will have to be considered in any future study 
of this nature.
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